GovWire

Guidance: ARSAC notes for guidance: good clinical practice in nuclear medicine

Administration Of Radioactive Substances Advisory Committee

February 7
15:25 2020

Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email arsac@phe.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance to good clinical practice for nuclear medicine in the UK is the advice of the Administration of Radioactive Substances Advisory Committee (ARSAC).

These notes update the 2019 edition to provide further clarification to employers and practitioners on the licencing process for the administration of radioactive substances.

Additional information is also provided on the ARSAC approval process for research studies involving the administration of radioactive substances.

Published 17 April 2014
Last updated 7 February 2020 +show all updates
  1. Updated 'Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources'.

  2. Updated notes to clarify the licencing process.

  3. Replaced 'notes for guidance' document and updated detail text.

  4. Uploaded the 2017 edition of guidance.

  5. January 2016 update to guidance.

  6. First published.

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: